stella
beta
Perioperative Tislelizumab Plus Chemotherapy for Resectable Thoracic Oesophageal Squamous Cell Carcinoma — Stella
Recruiting
Back to Esophageal Squamous Cell Carcinoma trials
Phase 2 — Testing in a larger group (up to a few hundred people) to further evaluate safety and begin to assess effectiveness.
Trial locations
(1 site)
China
Shanghai chest hospital, Shanghai, Shanghai Municipality
View full record on ClinicalTrials.gov